Izen Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 15-11-2024
- Paid Up Capital ₹ 0.20 M
as on 15-11-2024
- Company Age 19 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.95 M
as on 15-11-2024
- Revenue %
(FY 2023)
- Profit 44.46%
(FY 2023)
- Ebitda 44.46%
(FY 2023)
- Net Worth -25.50%
(FY 2023)
- Total Assets -20.70%
(FY 2023)
About Izen Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company has closed loans amounting to ₹1.95 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shivendra Punia and Devendra Punia serve as directors at the Company.
- CIN/LLPIN
U24232RJ2005PTC021757
- Company No.
021757
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Izen Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivendra Punia  | Director | 14-Dec-2005 | Current |
| Devendra Punia | Director | 02-Feb-2021 | Current |
Financial Performance of Izen Formulations.
Izen Formulations Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 44.46% increase in profit. The company's net worth observed a substantial decline by a decrease of 25.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Izen Formulations?
In 2023, Izen Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Marugandha Enterprises Private LimitedActive 10 years 11 monthsShivendra Punia and Devendra Punia are mutual person
- Daksh Handicrafts Private LimitedActive 18 years 7 months
Shivendra Punia and Devendra Punia are mutual person
- Human Potential Fellowship Foundation IndiaActive 3 years 4 months
Devendra Punia is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 23 Jan 2008 | ₹1.50 M | Satisfied |
Punjab National Bank Creation Date: 29 Mar 2007 | ₹0.45 M | Satisfied |
How Many Employees Work at Izen Formulations?
Unlock and access historical data on people associated with Izen Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Izen Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Izen Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
